Selected research
Industry Research
Lung Tumor Ablation Industry Research Report 2026
Market perspective
The global Lung Tumor Ablation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Lung Tumor Ablation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Lung Tumor Ablation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Lung Tumor Ablation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Lung Tumor Ablation include Angiodynamics, Auris Health, Intuitive Surgica, Nanjing MICRO-TECH, Smith and Nephew, VISON Medical, Olympus, Boston Scientific and Broncus, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Lung Tumor Ablation market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Lung Tumor Ablation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lung Tumor Ablation Market by Company
Angiodynamics
Auris Health
Intuitive Surgica
Nanjing MICRO-TECH
Smith and Nephew
VISON Medical
Olympus
Boston Scientific
Broncus
LungCare
Medtronic
TIPC
Lung Tumor Ablation Segment by Type
Microwave Ablation (MWA)
Radiofrequency Ablation (RFA)
Cold Ablation
Others
Lung Tumor Ablation Segment by Application
Hospitals
Ambulatory Surgical Centers
Lung Tumor Ablation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lung Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Tumor Ablation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Lung Tumor Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microwave Ablation (MWA)
- Radiofrequency Ablation (RFA)
- Cold Ablation
- Others
Applications
- Hospitals
- Ambulatory Surgical Centers
Companies covered
- Angiodynamics
- Auris Health
- Intuitive Surgica
- Nanjing MICRO-TECH
- Smith and Nephew
- VISON Medical
- Olympus
- Boston Scientific
- Broncus
- LungCare
- Medtronic
- TIPC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Lung Tumor Ablation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Microwave Ablation (MWA)
- 2.2.3 Radiofrequency Ablation (RFA)
- 2.2.4 Cold Ablation
- 2.2.5 Others
- 2.3 Lung Tumor Ablation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Ambulatory Surgical Centers
- 2.4 Assumptions and Limitations
3 Lung Tumor Ablation Breakdown Data by Type
- 3.1 Global Lung Tumor Ablation Historic Market Size by Type (2021-2026)
- 3.2 Global Lung Tumor Ablation Forecasted Market Size by Type (2027-2032)
4 Lung Tumor Ablation Breakdown Data by Application
- 4.1 Global Lung Tumor Ablation Historic Market Size by Application (2021-2026)
- 4.2 Global Lung Tumor Ablation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Lung Tumor Ablation Market Perspective (2021-2032)
- 5.2 Global Lung Tumor Ablation Growth Trends by Region
- 5.2.1 Global Lung Tumor Ablation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Lung Tumor Ablation Historic Market Size by Region (2021-2026)
- 5.2.3 Lung Tumor Ablation Forecasted Market Size by Region (2027-2032)
- 5.3 Lung Tumor Ablation Market Dynamics
- 5.3.1 Lung Tumor Ablation Industry Trends
- 5.3.2 Lung Tumor Ablation Market Drivers
- 5.3.3 Lung Tumor Ablation Market Challenges
- 5.3.4 Lung Tumor Ablation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Lung Tumor Ablation Players by Revenue
- 6.1.1 Global Top Lung Tumor Ablation Players by Revenue (2021-2026)
- 6.1.2 Global Lung Tumor Ablation Revenue Market Share by Players (2021-2026)
- 6.2 Global Lung Tumor Ablation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Lung Tumor Ablation Head Office and Area Served
- 6.4 Global Lung Tumor Ablation Players, Product Type & Application
- 6.5 Global Lung Tumor Ablation Manufacturers Established Date
- 6.6 Global Lung Tumor Ablation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Lung Tumor Ablation Market Size (2021-2032)
- 7.2 North America Lung Tumor Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Lung Tumor Ablation Market Size by Country (2021-2026)
- 7.4 North America Lung Tumor Ablation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Lung Tumor Ablation Market Size (2021-2032)
- 8.2 Europe Lung Tumor Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Lung Tumor Ablation Market Size by Country (2021-2026)
- 8.4 Europe Lung Tumor Ablation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Lung Tumor Ablation Market Size (2021-2032)
- 9.2 Asia-Pacific Lung Tumor Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Lung Tumor Ablation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Lung Tumor Ablation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Lung Tumor Ablation Market Size (2021-2032)
- 10.2 South America Lung Tumor Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Lung Tumor Ablation Market Size by Country (2021-2026)
- 10.4 South America Lung Tumor Ablation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Lung Tumor Ablation Market Size (2021-2032)
- 11.2 Middle East & Africa Lung Tumor Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Lung Tumor Ablation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Lung Tumor Ablation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Angiodynamics
- 12.1.1 Angiodynamics Company Information
- 12.1.2 Angiodynamics Business Overview
- 12.1.3 Angiodynamics Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.1.4 Angiodynamics Lung Tumor Ablation Product Portfolio
- 12.1.5 Angiodynamics Recent Developments
- 12.2 Auris Health
- 12.2.1 Auris Health Company Information
- 12.2.2 Auris Health Business Overview
- 12.2.3 Auris Health Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.2.4 Auris Health Lung Tumor Ablation Product Portfolio
- 12.2.5 Auris Health Recent Developments
- 12.3 Intuitive Surgica
- 12.3.1 Intuitive Surgica Company Information
- 12.3.2 Intuitive Surgica Business Overview
- 12.3.3 Intuitive Surgica Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.3.4 Intuitive Surgica Lung Tumor Ablation Product Portfolio
- 12.3.5 Intuitive Surgica Recent Developments
- 12.4 Nanjing MICRO-TECH
- 12.4.1 Nanjing MICRO-TECH Company Information
- 12.4.2 Nanjing MICRO-TECH Business Overview
- 12.4.3 Nanjing MICRO-TECH Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.4.4 Nanjing MICRO-TECH Lung Tumor Ablation Product Portfolio
- 12.4.5 Nanjing MICRO-TECH Recent Developments
- 12.5 Smith and Nephew
- 12.5.1 Smith and Nephew Company Information
- 12.5.2 Smith and Nephew Business Overview
- 12.5.3 Smith and Nephew Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.5.4 Smith and Nephew Lung Tumor Ablation Product Portfolio
- 12.5.5 Smith and Nephew Recent Developments
- 12.6 VISON Medical
- 12.6.1 VISON Medical Company Information
- 12.6.2 VISON Medical Business Overview
- 12.6.3 VISON Medical Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.6.4 VISON Medical Lung Tumor Ablation Product Portfolio
- 12.6.5 VISON Medical Recent Developments
- 12.7 Olympus
- 12.7.1 Olympus Company Information
- 12.7.2 Olympus Business Overview
- 12.7.3 Olympus Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.7.4 Olympus Lung Tumor Ablation Product Portfolio
- 12.7.5 Olympus Recent Developments
- 12.8 Boston Scientific
- 12.8.1 Boston Scientific Company Information
- 12.8.2 Boston Scientific Business Overview
- 12.8.3 Boston Scientific Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.8.4 Boston Scientific Lung Tumor Ablation Product Portfolio
- 12.8.5 Boston Scientific Recent Developments
- 12.9 Broncus
- 12.9.1 Broncus Company Information
- 12.9.2 Broncus Business Overview
- 12.9.3 Broncus Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.9.4 Broncus Lung Tumor Ablation Product Portfolio
- 12.9.5 Broncus Recent Developments
- 12.10 LungCare
- 12.10.1 LungCare Company Information
- 12.10.2 LungCare Business Overview
- 12.10.3 LungCare Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.10.4 LungCare Lung Tumor Ablation Product Portfolio
- 12.10.5 LungCare Recent Developments
- 12.11 Medtronic
- 12.11.1 Medtronic Company Information
- 12.11.2 Medtronic Business Overview
- 12.11.3 Medtronic Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.11.4 Medtronic Lung Tumor Ablation Product Portfolio
- 12.11.5 Medtronic Recent Developments
- 12.12 TIPC
- 12.12.1 TIPC Company Information
- 12.12.2 TIPC Business Overview
- 12.12.3 TIPC Revenue in Lung Tumor Ablation Business (2021-2026)
- 12.12.4 TIPC Lung Tumor Ablation Product Portfolio
- 12.12.5 TIPC Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst